Henry Schein PE Ratio 2010-2024 | HSIC
Current and historical p/e ratio for Henry Schein (HSIC) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Henry Schein PE ratio as of January 31, 2025 is 18.97.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Henry Schein PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-01-31 |
80.00 |
|
28.99 |
| 2024-09-30 |
72.90 |
$2.76 |
26.41 |
| 2024-06-30 |
64.10 |
$3.04 |
21.09 |
| 2023-12-31 |
75.71 |
$3.15 |
24.03 |
| 2023-09-30 |
74.25 |
$3.36 |
22.10 |
| 2023-06-30 |
81.10 |
$3.03 |
26.77 |
| 2023-03-31 |
81.54 |
$3.06 |
26.65 |
| 2022-12-31 |
79.87 |
$3.31 |
24.13 |
| 2024-03-31 |
75.52 |
$4.27 |
17.69 |
| 2022-09-30 |
65.77 |
$4.60 |
14.30 |
| 2022-06-30 |
76.74 |
$4.66 |
16.47 |
| 2022-03-31 |
87.19 |
$4.60 |
18.95 |
| 2021-12-31 |
77.53 |
$4.46 |
17.38 |
| 2021-09-30 |
76.16 |
$4.41 |
17.27 |
| 2021-06-30 |
74.19 |
$4.25 |
17.46 |
| 2021-03-31 |
69.24 |
$3.07 |
22.55 |
| 2020-12-31 |
66.86 |
$2.82 |
23.71 |
| 2020-09-30 |
58.78 |
$4.06 |
14.48 |
| 2020-06-30 |
58.39 |
$4.02 |
14.52 |
| 2020-03-31 |
50.52 |
$4.87 |
10.37 |
| 2019-12-31 |
66.72 |
$4.69 |
14.23 |
| 2019-09-30 |
63.50 |
$3.32 |
19.13 |
| 2019-06-30 |
69.90 |
$3.16 |
22.12 |
| 2019-03-31 |
60.11 |
$3.31 |
18.16 |
| 2018-12-31 |
78.52 |
$3.49 |
22.50 |
| 2018-09-30 |
85.03 |
$2.56 |
33.21 |
| 2018-06-30 |
72.64 |
$2.64 |
27.52 |
| 2018-03-31 |
67.21 |
$2.58 |
26.10 |
| 2017-12-31 |
69.88 |
$2.53 |
27.62 |
| 2017-09-30 |
81.99 |
$3.41 |
24.08 |
| 2017-06-30 |
91.51 |
$3.27 |
28.03 |
| 2016-12-31 |
75.86 |
$3.10 |
24.51 |
| 2016-09-30 |
81.49 |
$3.01 |
27.07 |
| 2016-06-30 |
88.40 |
$3.08 |
28.75 |
| 2016-03-31 |
86.32 |
$3.11 |
27.80 |
| 2015-12-31 |
79.10 |
$3.12 |
25.35 |
| 2017-03-31 |
84.99 |
$2.95 |
28.81 |
| 2015-09-30 |
66.36 |
$2.85 |
23.28 |
| 2015-06-30 |
71.06 |
$2.76 |
25.75 |
| 2015-03-31 |
69.81 |
$2.65 |
26.34 |
| 2014-12-31 |
68.08 |
$2.76 |
24.71 |
| 2014-09-30 |
58.24 |
$2.59 |
22.48 |
| 2014-03-31 |
59.69 |
$2.54 |
23.54 |
| 2013-12-31 |
57.13 |
$2.46 |
23.22 |
| 2013-09-30 |
51.88 |
$2.38 |
21.85 |
| 2013-06-30 |
47.87 |
$2.30 |
20.81 |
| 2013-03-31 |
46.28 |
$2.23 |
20.80 |
| 2012-12-31 |
40.21 |
$2.16 |
18.66 |
| 2012-09-30 |
39.61 |
$2.10 |
18.86 |
| 2012-06-30 |
39.25 |
$2.06 |
19.10 |
| 2012-03-31 |
37.84 |
$2.02 |
18.73 |
| 2011-12-31 |
32.22 |
$1.99 |
16.23 |
| 2011-09-30 |
31.01 |
$1.91 |
16.23 |
| 2011-06-30 |
35.80 |
$1.89 |
18.99 |
| 2011-03-31 |
35.09 |
$1.83 |
19.17 |
| 2010-12-31 |
30.70 |
$1.75 |
17.54 |
| 2010-09-30 |
29.29 |
$1.72 |
17.03 |
| 2010-06-30 |
27.45 |
$1.78 |
15.46 |
| 2010-03-31 |
29.45 |
$1.73 |
17.02 |
| 2009-12-31 |
26.30 |
$2.08 |
12.67 |
| 2009-09-30 |
27.46 |
$1.91 |
14.37 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$9.958B |
$12.339B |
|
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
|
